Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Belch

Showing results (111-120 of 181) with videos related to

Pageof 19
Sort By:
Rheumatology International|January 1, 1991
The effects of thromboxane receptor blockade on platelet aggregation and digital skin blood flow in patients with secondary Raynaud's syndromeC S Lau, F Khan, M McLaren, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 1, 1991
The relationship of oxidative stress to thrombotic tendency in type 1 diabetic patients with retinopathyP E Jennings, M McLaren, N A Scott, et al.
European Heart Journal|December 1, 1992
Circadian variation of white blood cell aggregation and free radical indices in men with ischaemic heart diseaseA B Bridges, N A Scott, G P McNeill, et al.
Haemostasis|January 1, 1987
Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole bloodA R Saniabadi, J J Belch, G D Lowe, et al.
Lancet (London, England)|May 25, 1985
Double-blind trial of CL115,347, a transdermally absorbed prostaglandin E2 analogue, in treatment of Raynaud's phenomenonJ J Belch, R Madhok, B Shaw, et al.
Journal of Clinical Pathology|April 1, 1980
An assessment of red cell deformability using a simple filtration methodM M Drummond, G D Lowe, J J Belch, et al.
Scottish Medical Journal|April 1, 1981
Prevention of deep vein thrombosis in medical patients by low-dose heparinJ J Belch, G D Lowe, A G Ward, et al.
Clinical Rheumatology|March 1, 1988
A double blind randomised placebo controlled trial of hexopal in primary Raynaud's diseaseG T Sunderland, J J Belch, R D Sturrock, et al.
Immunology|May 1, 1985
Isolation of labile Fcgamma-receptors from human peripheral blood lymphocytes and production of an antiserumG P Sandilands, M G Peel, K S Froebel, et al.
Clinical Cardiology|March 1, 1992
Relationship between the extent of coronary artery disease and indicators of free radical activityA B Bridges, N A Scott, T H Pringle, et al.
Pageof 19

Showing results (111-120 of 181) with videos related to

Sort By:
Pageof 19
Rheumatology International|January 1, 1991
The effects of thromboxane receptor blockade on platelet aggregation and digital skin blood flow in patients with secondary Raynaud's syndromeC S Lau, F Khan, M McLaren, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 1, 1991
The relationship of oxidative stress to thrombotic tendency in type 1 diabetic patients with retinopathyP E Jennings, M McLaren, N A Scott, et al.
European Heart Journal|December 1, 1992
Circadian variation of white blood cell aggregation and free radical indices in men with ischaemic heart diseaseA B Bridges, N A Scott, G P McNeill, et al.
Haemostasis|January 1, 1987
Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole bloodA R Saniabadi, J J Belch, G D Lowe, et al.
Lancet (London, England)|May 25, 1985
Double-blind trial of CL115,347, a transdermally absorbed prostaglandin E2 analogue, in treatment of Raynaud's phenomenonJ J Belch, R Madhok, B Shaw, et al.
Journal of Clinical Pathology|April 1, 1980
An assessment of red cell deformability using a simple filtration methodM M Drummond, G D Lowe, J J Belch, et al.
Scottish Medical Journal|April 1, 1981
Prevention of deep vein thrombosis in medical patients by low-dose heparinJ J Belch, G D Lowe, A G Ward, et al.
Clinical Rheumatology|March 1, 1988
A double blind randomised placebo controlled trial of hexopal in primary Raynaud's diseaseG T Sunderland, J J Belch, R D Sturrock, et al.
Immunology|May 1, 1985
Isolation of labile Fcgamma-receptors from human peripheral blood lymphocytes and production of an antiserumG P Sandilands, M G Peel, K S Froebel, et al.
Clinical Cardiology|March 1, 1992
Relationship between the extent of coronary artery disease and indicators of free radical activityA B Bridges, N A Scott, T H Pringle, et al.
Pageof 19